Evidence map›Paper›PMID 42182629›Full record

ArticleJournal of thoracic disease2026

Adverse side-effects of antifibrotic drugs in idiopathic pulmonary fibrosis-clarification of several points.

Dragana Jovanovic, Nesrin Mogulkoc, Martina Sterclova, Mordechai Kramer, Veronika Müller, Vladimir Bartos, Martina Plackova, Martina Doubkova, Katarzyna Lewandowska, Amelia Szymanowska-Narloch and 3 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dragana JovanovicAkta Medica Clinic, Belgrade, Serbia.
Nesrin MogulkocDepartment of Pulmonary Medicine, Ege University, Izmir, Turkey.
Martina SterclovaDepartment of Respiratory Medicine, First Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic.
Mordechai KramerInstitute of Pulmonary and Allergy Medicine, Rabin Medical Centre, Petah Tikva, Israel.
Veronika MüllerDepartment of Pulmonology, Semmelweis University, Budapest, Hungary.
Vladimir BartosDepartment of Pulmonology, University Hospital Hradec Králové, Hradec Králové, Czech Republic.
Martina PlackovaDepartment of Pneumology, University Hospital Ostrava, Ostrava, Czech Republic.
Martina DoubkovaDepartment of Pulmonology, University Hospital Brno, Brno, Czech Republic.
Katarzyna LewandowskaFirst Department of Pulmonary Diseases, Institute of Tuberculosis and Lung Diseases, Warsaw, Poland.
Amelia Szymanowska-NarlochAllergology and Pneumonology Department, University Hospital Gdańsk, Gdańsk, Poland.
Monika ZurkovaDepartment of Pulmonology, University Hospital Olomouc, Olomouc, Czech Republic.
Petra OvesnaInstitute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Martina Koziar VasakovaDepartment of Respiratory Medicine, First Faculty of Medicine, Charles University, Thomayer University Hospital, Prague, Czech Republic.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42182629
PMCPMC13190029

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.